Edition:
United Kingdom

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

440.25INR
10:28am GMT
Change (% chg)

Rs4.15 (+0.95%)
Prev Close
Rs436.10
Open
Rs436.30
Day's High
Rs442.90
Day's Low
Rs425.60
Volume
552,311
Avg. Vol
1,007,165
52-wk High
Rs560.00
52-wk Low
Rs329.40

Chart for

About

Cadila Healthcare Limited is an India-based pharmaceutical company. The Company's subsidiaries include Zydus Wellness Limited, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited, German Remedies Limited, Dialforhealth India Limited, Dialforhealth Unity Limited and Dialforhealth... (more)

Overall

Beta: 0.50
Market Cap(Mil.): Rs511,564.19
Shares Outstanding(Mil.): 1,023.74
Dividend: 3.20
Yield (%): 0.96

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clomipramine Hydrochloride Capsules

* SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CLOMIPRAMINE HYDROCHLORIDE CAPSULES USP

29 Dec 2017

BRIEF-Cadila Healthcare Says ‍Zydus Gets U.S.FDA Nod For Drug to Treat Hypertension, Chest Pain

* SAYS ‍ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR NIFEDIPINE EXTENDED-RELEASE TABLETS USP​

21 Dec 2017

BRIEF-Cadila Healthcare Says ‍Zydus Got USFDA Nod For Two Drugs

* ‍ZYDUS GETS FINAL APPROVAL FROM USFDA FOR PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS & NITROFURANTOIN CAPSULES USP (MACROCRYSTALS)​

14 Dec 2017

BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clozapine Tablets

* SAYS ZYDUS GET FINAL NOD FROM U.S. FDA FOR CLOZAPINE TABLETS USP

08 Dec 2017

BRIEF-Cadila Healthcare Says Zydus Gets Tentative Approval From U.S. FDA For Pregabalin Capsules

* SAYS ZYDUS GETS TENTATIVE APPROVAL FROM U.S. FDA FOR PREGABALIN CAPSULES

01 Dec 2017

BRIEF-Cadila Healthcare's Zydus, ICMR Launch Diagnostic Kits To Detect Rare Infectious Diseases

* INDIAN COUNCIL OF MEDICAL RESEARCH, ZYDUS LAUNCH DIAGNOSTIC KITS TO DETECT NEGLECTED INFECTIOUS DISEASES IN LIVESTOCK

29 Nov 2017

BRIEF-Cadila Healthcare Says ‍Zydus Gets Final Nod From U.S. FDA For Candesartan Cilexetil And Hydrochlorothiazide Tablets​

* SAYS ‍ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS

29 Nov 2017

BRIEF-Cadila Healthcare's ‍Zydus Gets Nod For Topiramate Extended-Release Capsules​

* ‍ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR TOPIRAMATE EXTENDED-RELEASE CAPSULES

27 Nov 2017

BRIEF-Zydus Cadila's anemia developmental candiate ZYAN1 named as Desidustat by WHO‍​

* WHO INN committee grants name Desidustat to Zydus Cadila's phase II anemia candidate, Zyan1‍​

20 Nov 2017

BRIEF-India's Cadila Healthcare Sept-qtr consol profit up about 32 pct

* Sept quarter consol net profit 5.03 billion rupees versus profit of 3.80 billion rupees last year

14 Nov 2017

Earnings vs. Estimates